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Abstract
Background: The regulation of Notch signaling heavily relies on ubiquitination events. Drosophila Su(dx), a member of the
HECT family of ubiquitin-ligases, has been described as a negative regulator of Notch signaling, acting on the post-
endocytic sorting of Notch. The mammalian ortholog of Su(dx), Itch/AIP4, has been shown to have multiple substrates,
including Notch, but the precise events regulated by Itch/AIP4 in the Notch pathway have not been identified yet.
Methodology/Principal Findings: Using Itch-/- fibroblasts expressing the Notch1 receptor, we show that Itch is not
necessary for Notch activation, but rather for controlling the degradation of Notch in the absence of ligand. Itch is indeed
required after the early steps of Notch endocytosis to target it to the lysosomes where it is degraded. Furthermore Itch/AIP4
catalyzes Notch polyubiquitination through unusual K29-linked chains. We also demonstrate that although Notch is
associated with Itch/AIP4 in cells, their interaction is not detectable in vitro and thus requires either a post-translational
modification, or a bridging factor that remains to be identified.
Conclusions/Significance: Taken together our results identify a specific step of Notch regulation in the absence of any
activation and underline differences between mammalian and Drosophila Notch pathways.
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Introduction
Notch signaling is an evolutionarily conserved process involved
in cell fate decisions, cell proliferation or cell death, during
development and in the adulthood, and its deregulation leads to
several pathologies in mammals. The canonical Notch activation
pathway relies on the regulated proteolysis of this membrane
receptor after binding to one of its ligands. The resulting free
intracellular domain of Notch (ICv) translocates to the nucleus to
form a transcriptional activation complex with other cofactors [1].
Besides the various combinations of ligands and receptors
probably leading to various transcriptional responses, the quan-
titative aspects of the signaling pathway have to be controlled.
These regulations may occur at the level of the production and/or
stability of ICv, affinity of the receptor for its ligand, and quantity
of ligand and receptor present at the cell surface.
Suppressor of deltex (Su(dx)) was first described in Drosophila as
a negative regulator of Notch signaling, acting in an antagonist
manner to Deltex (dx), another component of the pathway [2–4].
The phenotypes resulting from the overexpression of the Su(dx)
protein in the developing wing were those expected from a
downregulation of the Notch pathway. Mammalian orthologs of
Su(dx) are called Itch in the mouse and AIP4 in humans.
Mammalian Itch was identified in natural mutant mice (itchy
mice, [5]) that develop a progressive autoimmune-like disease,
partly because Itch targets such as junB are relevant to
autoimmunity. However it was recently shown that increased
Notch signaling in transgenic mice mimics the symptoms of the
disease [6]. Various substrates have been described for Itch in
mammals: CXCR4 [7], p73, p63 [8,9] smad 7 [10], Jun [11],
Deltex (DTX, [12]) and Endophilin [13]. In general Itch targets its
substrates to degradation, with some exceptions: AIP4 regulates
the cell surface expression of select TRP channels by enhancing
their ubiquitination and endocytosis but without facilitating their
degradation [14]. Itch activity on junB is enhanced by Ser/Thr
phosphorylation by MEKK1-JNK1 kinases [11], and reduced by
Tyr phosphorylation in a fyn-dependent manner [15]. Thus it is
difficult to attribute general characteristics to Itch, except that it is
located in the endosomal system [7,13,16] and that it is
autoubiquitinated [12,17]. Furthermore the type of chains formed
on its substrates is not often identified (except for K29-linked
polyubiquitin chains on DTX and itself, [12]). Even less is known
in Drosophila about the mechanisms controlled by Su(dx), Notch
being its unique described target in this organism. Sakata et al.
[18] have shown that ubiquitination of Drosophila Notch depends
on Nedd4 (an E3 ubiquitin ligase belonging to the same family as
Su(dx)) and on the presence of a PPSY motif in the intracellular
region of Notch. Nedd4 is involved in the constitutive endocytosis
of Notch and regulates its stability. Wilkin et al. [19] have
demonstrated that Su(dx) and/or Nedd4 regulate sorting of Notch
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not determine whether ubiquitination of Notch targets it for
degradation, recycling or some other fate.
In mammals, Qiu et al [20] have shown that Itch is able to
direct the ubiquitination of Notch DE (a constitutively active but
membrane-anchored form of Notch). Based on interaction
experiments, they concluded that the Notch IC domain is a direct
substrate for Itch. However the step regulated by Itch was not
clearly defined.
As these conclusions on the role of Itch on an activated form of
mammalian Notch contradict the observations made in Drosoph-
ila, we decided to identify the form of Notch that was targeted by
Itch, and to characterize the consequences of this ubiquitination.
We demonstrate here that Itch controls the degradation of the
non-activated receptor, inducing after early endocytosis the
formation of K29-linked polyubiquitin chains and targeting Notch
to lysosomal degradation. We also show that Itch does not interact
directly with Notch in mammals and might require a bridging
factor.
Results
Notch activation does not depend on Itch
It has been shown in Drosophila that Notch signaling is limited
by the activity of Su(dx) and DNedd4. In addition the inhibition of
Nedd4 activity leads to ligand-independent activation of Notch
[18]. To test whether the absence of Itch had any consequence on
Notch activation in a mammalian system, we transduced MEFs
with retroviral vectors to allow expression of human Notch 1 at the
cell surface. In this vector an HA tag sequence has been inserted
between EGF repeats 22 and 23 of Notch [21]. These cells, either
WT (called MD-FL) or Itch-/- (ID-FL), have also been stably
transfected by a VSV-tagged version of hDTX1 [12]. Notch
activation was obtained by separation of its heterodimeric form
following calcium depletion by EDTA [21]. This well documented
method allows the rapid and efficient activation of Notch
throughout a cell population. Notch activation was monitored
by the presence of the Notch intracellular fragment (ICv) in the
extracts, detected with the specific V1744 N-terminal antibody
(Figure 1). No activated form was detected in the extracts derived
from both cell lines, showing that Notch was not constitutively
activated in Itch-/- cells (lanes 1 and 4). EDTA treatment led to
the production of comparable amounts of ICv in both cell lines
(lanes 2 and 5). ICv was also clearly detectable by direct blotting
with an anti-Notch IC antibody (compare lanes 8, 11 to 7, 10).
EDTA activation of Notch was dependent both on c-secretase
activity, since DAPT (a c-secretase inhibitor) treatment abolishes
ICv production (lanes 3, 6), and on the membrane metalloprotease
TACE, since the S2 cleavage product accumulated in the presence
of DAPT (lanes 9, 12, open arrowhead). Thus in the absence of
Itch, Notch receptor was fully functional and no ectopic activation
was observed. Therefore the increased Notch signaling in Itch -/-
mice [6] might be rather due to a defect in its negative regulation.
Notch receptor in the absence of ligand is targeted to
lysosomal degradation in an Itch-dependent manner
As the relative quantity of Notch at the membrane was the same
in MD-FL and ID-FL cells (Figure S1), we wanted to establish
whether Itch regulates the postendocytic sorting of Notch
independently of ligand binding. We monitored Notch 1
internalization by an antibody uptake experiment in the absence
of any ligand. Notch 1 in MD-FL or ID-FL cells was detected with
the use of an extracellular HA epitope (figure 2, 0 min). The cells
were incubated with a fluorescently labeled anti-HA antibody at
4uC for 30 minutes, then incubated at 37uC for various periods of
time, fixed and observed to track the destination of cell surface-
localized Notch. Notch receptor incubation with anti-HA antibody
did not provoke Notch activation, since no nuclear staining with
anti-activated Notch antibody was observed (data not shown).
Furthermore the staining pattern, observed with an anti-Notch
Figure 1. Notch activation by EDTA in WT (MD-FL) and Itch-/- (ID-FL) cells. Cells were activated by a 15 minutes EDTA treatment, in the
presence of DAPT when indicated. Extracts were then directly prepared and tested by immunoblotting with antibodies recognizing the activated
form of Notch (V1744 antibody, lanes 1 to 6), or the whole intracellular domain (Notch IC antibody, lanes 7 to 12). The open arrowhead indicates the
S2 cleavage product appearing after Notch activation. p300 and p120 represent respectively the Notch precursor and its furin-generated
transmembrane product.
doi:10.1371/journal.pone.0002735.g001
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whether cells had been treated with anti-HA or not (data not
shown). After a 30 min incubation at 37uC, much of the Notch
immunoreactivity was detected in intracellular vesicles, suggesting
that cell surface Notch is constantly internalized in WT as well as
in Itch -/- cells (Figure 2, line 30 min). After 60 and 90 minutes,
almost no HA staining was detectable in MD-FL cells (first
column), suggesting that Notch or the HA antibody had been
degraded. Concomitant treatment with the proteasome inhibitor
lactacystin did not affect this kinetics, whereas inhibition of
lysosomal proteases by leupeptin treatment prolonged the HA
staining at least until 90 minutes of internalization (MD-FL+leu-
peptin). In contrast, in ID-FL cells, HA staining was visible after 60
or 90 minutes of incubation, irrespective of lactacystin or
leupeptin treatment (see quantification, figure 2 bottom). On the
other hand, EGFR degradation after EGF activation, monitored
in the same type of assay with uptake of fluorescent EGF, was
identical after a 60 min incubation time in MD-FL and in ID-FL
cells (Figure S2, compare MD-FL in A to ID-FL in B). Thus the
ID-FL cells are not impaired in a general lysosomal activity or in
the endocytic pathway. These results suggest that HA staining
disappearance in MD-FL cells is due to Notch degradation in the
lysosomes. In ID-FL cells Notch degradation was strongly delayed.
Moreover in these cells the Notch-positive endocytic vesicles,
detected at 30 minutes (Figure 2) were more scattered throughout
the cells, as compared to MD-FL cells. We confirmed these results
by co-labelling LAMP-1 after cell fixation and permeabilisation.
At 90 minutes of Notch internalization, the HA-positive vesicles in
ID-FL were essentially negative for the lysosomal marker LAMP-1
(Figure 3), whether the cells have been treated with leupeptin or
Figure 2. Notch endocytosis and degradation. Pulse-chase antibody uptake assay on MD-FL or ID-FL cells. Alexa 488-coupled anti-HA antibody
(green) was taken into the cells by endocytosis during various periods of time at 37uC. When indicated, cells were incubated 1 h before adding
antibody with leupeptin or lactacystin, and maintained during the entire experiment in the presence of these inhibitors. The data are representative
of 4 independent experiments. Bottom, quantification of Notch degradation: the percentage of cells showing HA staining after 60 or 90 minutes of
incubation was calculated as an average from at least 40 cells providing from 4 independent experiments.
doi:10.1371/journal.pone.0002735.g002
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accumulated in LAMP-1 positive vesicles, showing that it had
reached the lysosomes. These results suggest that Notch targeting
and degradation in the lysosomes depends on the activity of Itch.
To confirm that the presence of Itch is important for this late
targeting, we prepared endocytic fractions from MD-FL and ID-
FL cells. Notch full-length molecule (indicated as p300 in figure 4A)
was detectable in the post-nuclear supernatant (P in lanes 1, 4, 7,
10), and very poorly in the early endosomal fractions (E, lanes 2, 5,
8, 11), confirming the non-contamination of our preparations with
Golgi or endoplasmic reticulum proteins [22]. This was further
verified thanks to an anti-GM130 (a Golgi protein) western
blotting (Figure 4B). The heterodimeric receptor, detected as p120
with an antibody recognizing the intracellular part of Notch 1, was
present in early endosomal fractions (E) in both MD-FL and ID-
FL cells, but in late endosomal fractions (L) only in MD-FL cells.
These fractions were enriched in p120 when MD-FL cells were
treated with leupeptin, confirming Notch 1 lysosomal degradation
(4A, lanes 7 to 9). Itch was mainly detected in E fraction, consistent
with its role in this compartment (4B, bottom panel). In ID-FL
cells, p120 was only detected in E fractions, irrespective of
leupeptin treatment (lanes 5–6 and 11–12). On the other hand,
EGFR fractionation was similar in both cell lines (Figure 4B), thus
validating the preparations. These results are in agreement with
Itch being necessary for Notch transition from early to late
endosomes, before lysosomal degradation. To further prove this
requirement, we transiently complemented ID-FL cells with AIP4
(Figure 5). Notch expression at the membrane was not affected by
overexpression of AIP4 (0 min). On the other hand, Notch
degradation was visible after 60 minutes of internalization time in
AIP4-transfected cells, whereas in the neighbouring non-trans-
fected cells, Notch was still detected in endocytic vesicles. This
result shows that AIP4 complementation is sufficient to restore
Notch targeting to lysosomal degradation.
Ubiquitination of Notch is dependent on Itch
In order to determine whether Itch acts on Notch through its
E3-ubiquitin ligase activity, we monitored Notch ubiquitination by
transfecting 293T cells with expression vectors encoding 66His-
tagged Ubiquitin together with Notch FL(2CT) (deleted of the C-
Figure 3. Notch degradation occurs in the lysosomes. The anti-HA antibody uptake assay was performed as in figure 2. After 90 minutes of
chase, cells were fixed, permeabilized and incubated with an anti-LAMP-1 antibody, followed by a mouse-adsorbed rabbit anti-rat and then Al555-
coupled anti-rabbit antibodies. Insets represent enlargements (fourfold) of the boxed regions. The photographs are representative of a large number
of observed fields. The relative amount of Notch-containing vesicles also positive for LAMP-1 was calculated from 10 cells in each condition. In
average less than 25% of Notch vesicles were LAMP-1 negative in MD-FL+Leupeptin, whereas less than 25% of Notch vesicles were positive for LAMP-
1 in ID-FL cells (+/2 Leupeptin).
doi:10.1371/journal.pone.0002735.g003
Regulation of Notch by Itch
PLoS ONE | www.plosone.org 4 July 2008 | Volume 3 | Issue 7 | e2735terminal domain, amino-acids 1 to 2183 of Notch1, see [23]),
AIP4 or an inactive form of AIP4, carrying a mutation in the
active site (named AIP4DN). Ni2+-chelating sepharose was used to
purify the ubiquitinated conjugates in denaturing conditions (8M
urea), and the ubiquitination levels of Notch were analyzed by
immunoblotting. When 66HIS-Ub was coexpressed (Figure 6A,
lanes 2–4), we specifically detected a monoubiquitinated Notch
species (indicated by *), as well as a smear representing the
polyubiquitinated forms (indicated by Ub-Notch). Overexpressing
AIP4 enhanced Notch polyubiquitination (lane 3), whereas
AIP4DN overexpression severely impaired it (lane 4). To identify
the type of isopeptide linkage catalysed on Notch, we made use of
expression vectors encoding VSV-tagged ubiquitins, allowing the
formation of a single type of polyubiquitin chains [12]. After 293T
cells transfection with Notch FL(HA) (which contains the carboxy-
terminal sequence of Notch1), AIP4 and ubiquitin expression
vectors, extracts were boiled in SDS-containing buffer, before
immunoprecipitation with anti-Notch antibody and detection of
the ubiquitinated products with anti-VSV. Ubiquitination of
Notch was predominantly detected when using Ub K29, as
compared with Ub K48 or K63 (Figure 6B, lanes 2–4). The fact
that polyubiquitinated products were detected in these denaturing
conditions strongly suggests that they are Notch products. We
verified by direct western blotting of the extracts that all ubiquitin
vectors allowed the expression and incorporation of the mutant
ubiquitins (Figure 6B, bottom). Finally, when monitoring EGFR
ubiquitination after EGF treatment, all ubiquitin vectors, includ-
ing Ub K0 (without any lysine) allowed the same smear to be
detected, showing that multiubiquitination was mostly produced,
as expected ([24], Figure S3). This confirmed that preferential K29
ubiquitination was not an artifact of our VSV-Ub vectors. The fact
that Notch polyubiquitination was detected with these VSV-
ubiquitin constructs, whereas monoubiquitination was predomi-
nant when using His-Ub was an artifact of the His-Ub constructs,
that we observed with various ubiquitination substrates and that
may be due to steric hindrance caused by the 66His tag.
Furthermore the effect of AIP4 WT or DN on Notch (2 or + CT)
ubiquitination was also seen with the VSV-ubiquitin expression
vectors (Figure S4). However only a mass spectrometry analysis of
Notch products would allow the identification of the ubiquitina-
Figure 4. Subcellular fractionation of Notch-expressing cells.
MD-FL or ID-FL cells (non-treated or after leupeptin treatment as
indicated) were mechanically lysed and a post-nuclear supernatant (P)
was prepared. Early (E) or late (L) endosomes were prepared by
floatation in a sucrose gradient, and blotted for the presence of Notch
in A. p300 is the full-length Notch molecule retained in the Golgi
apparatus before its maturation by furin protease, p120 is the mature
membrane-associated C-terminal part of the molecule. In B, the
fractions were analyzed with rabbit anti-EGFR, anti-GM130 (as a Golgi
marker) and monoclonal anti-Itch, as indicated on the left.
doi:10.1371/journal.pone.0002735.g004
Figure 5. AIP4 complementation in ID-FL cells. The anti-HA antibody uptake assay (see figure 2) was performed on ID-FL cells prealably
transfected with Flag-AIP4 expression vector. After 0 or 60 minutes of chase, cells were fixed, permeabilized and incubated with a CY3-coupled anti-
Flag antibody.
doi:10.1371/journal.pone.0002735.g005
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together, our results show that Notch, in the absence of ligand,
represents a new substrate of AIP4, submitted to the same
modification that we have described for Deltex [12].
In order to precisely identify the step where ubiquitination of
Notch by Itch takes place, we monitored Notch FL(2CT)
ubiquitination when early endocytosis was inhibited by overex-
pressing a dominant negative form of rab5 (rab5DN, fused to
GFP). As shown in figure 6C, Itch-dependent, K 29-linked
polyubiquitination (lanes 5–6) was largely diminished in the
presence of rab5DN (lanes 7–8), although Notch quantities were
comparable in the extracts (lanes 9–16) and in the immunopre-
cipitates (lanes 1–8, bottom). We concluded that Itch ubiquitinates
Notch after early endocytosis.
Interaction between Notch and Itch is not direct
In Drosophila Su(dx) and Notch interact directly through their
WW and PPSY motif respectively [18,19,25]. The PPSY
interaction motif of Drosophila Notch is transformed into PPRL
in mammals (aa 2260–2263 in Notch 1), a sequence which is
absent in the (2CT) form of Notch. However the presence of the
C-terminal domain of hNotch 1 is not necessary for Itch to
ubiquitinate Notch (see figure 6A and C). On the other hand Qiu
et al [20] have concluded that Itch binds to the N-terminal portion
of Notch intracellular domain. We thus examined whether the
interaction between Itch and Notch was direct, using GST fusion
proteins containing fragments of AIP4 bound to gluthatione-
agarose beads, and incubated with translation products obtained
in rabbit reticulocyte lysates. We used IC forms of Notch (2 and +
CT) to avoid the conformation problems due to the presence of
transmembrane domains. Figure 7 shows that the IC forms of
Notch could not efficiently interact with AIP4 in vitro (lanes 1, 4,
9, 12). Thus a post-translational modification of Notch or Itch
might be necessary to allow recognition. Alternatively it is possible
that the interaction needs a cofactor. We tested several proteins as
possible bridging factors between Notch and AIP4 in this test
assay. DTX (two concentrations, indicated with small or large + in
lanes 2–7 and 10–15) and numb (lanes 17–22) (see Discussion)
were specifically retained on GST-AIP4 in the presence or absence
of ICs. In spite of their presence, Notch was not better pulled-
down by GST-AIP4 (lanes 5, 6, 13, 14, 21, 22). The same results
were obtained when testing b-arrestin 1 or 2 (data not shown).
Notch and Itch overexpression and coimmunoprecipitation is
not a conclusive assay to demonstrate that Notch interacts with
Itch during its trafficking. Hence we decided to purify Notch and
Itch-containing complexes from MD-FL cells. We used a large
panel of detergents to solubilize membrane proteins, and notably
only digitonin allowed specific co-immunoprecipitation of Itch
with Notch (Figure 8). This was true when using antibodies
directed against either the extracellular part of the receptor (anti-
HA, lane 1) or its intracellular domain (Nic, lane 2), suggesting an
interaction with the heterodimeric form of Notch. In addition a
long exposure of anti-Itch immunoprecipitate immunoblotted with
anti-Notch allowed the detection of the p120 form (lane 4 of
Figure 6. AIP4 stimulates polyubiquitination of Notch through
K29-linked chains after early endocytosis. A. HEK293T were
transfected with Notch FL-CT, AIP4 WT or DN, and 66His-ubiquitin
expression vectors when indicated. His-Ub-conjugated forms of Notch
were purified in denaturing conditions on Ni+-sepharose (lanes 1–4)
and tested by immunoblotting with anti-Notch IC. A Notch-containing
cell lysate was tested in parallel (lane 5) to visualize the non-
ubiquitinated Notch. The * indicates the starting point of the
ubiquitinated products derived from Notch. Bottom, the corresponding
cell extracts were directly analyzed with the same antibody. B. HEK293T
were transfected with Notch FL(HA), AIP4 and VSV-tagged ubiquitin
(Ub) expression vectors. The number indicates the only lysine residue
remaining in the ubiquitin molecule. Cell extracts were directly tested
for Notch (lanes 5–8) or Notch ubiquitinated products were purified via
denaturing immunoprecipitation (lanes 1–4) and revealed by anti-VSV
western blotting. Bottom, the cell extracts were directly analyzed by
SDS-PAGE on a 4–20% gradient gel followed by immunoblotting with
anti-VSV antibody, which revealed the free ubiquitin molecules (arrow)
and a smear corresponding to the ubiquitinated proteins in the whole
extracts. C. HEK293T were transfected with expression vectors encoding
for Notch FL(2CT), Ub K29, AIP4 (WT) and a dominant-negative form of
rab5 linked to GFP (rab5DN) when indicated. Notch products were
purified by immunoprecipitation and the ubiquitinated molecules were
revealed by anti-VSV (lanes 1–8) followed by anti-Notch (bottom)
western blotting. As controls, cell extracts were directly tested for
Notch, rab5 (anti-GFP) and Itch (lanes 9–16).
doi:10.1371/journal.pone.0002735.g006
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interacts indirectly with heterodimeric Notch in the cells.
Discussion
Role of Itch/AIP4 in Notch signaling
Modulating the amount of Notch receptor that is available for
signaling could provide one of the mechanisms to finely tune the
activity of the pathway. Therefore ubiquitination events and
endocytic trafficking of the receptor could constitute key events,
particularly in the light of the results showing that mutations that
compromise sorting of ubiquitinated membrane protein (ESCRT
components for instance) result in overactivation of Notch [26–
28]. Our results show that, in the absence of any activation,
mammalian Notch receptor is constitutively internalized and
degraded in the lysosomes. Notch degradation in the lysosomes is
abolished by treating the cells with leupeptin, whereas a
proteasomal inhibitor, lactacystin does not affect this event. Thus
the regulation of the quantity of functional Notch receptor occurs
mostly through its lysosomal degradation. This result seems
contradictory to what was proposed by others, who observed an
accumulation of drosophila Notch receptor in the presence of
MG101 or MG132 [18,29]. However these proteasome inhibitors,
unlike lactacystin, could also inhibit lysosomal Cys proteases [30],
or they could act indirectly on Notch stability. Recycling of Notch
receptor is not completely ruled out, in particular in the Itch -/-
cells, but this type of event should have been detected in our
antibody uptake experiment where the antibody used did not
dissociate from the receptor in a moderately acidic environment.
We show here that the initial steps of Notch endocytosis do not
depend on Itch/AIP4. However this E3 ubiquitin ligase is required
at a later step allowing final targeting to the lysosomes, since we
observe that Notch is still internalized in Itch-/- cells and
accumulates in endosomes that are adjacent to LAMP-1 positive
vesicles and that ubiquitination is impaired when early endocytosis
is blocked. It should be mentioned that although Notch
Figure 7. Notch does not interact directly with Itch/AIP4. The Notch IC+CT, IC-CT, numb and DTX proteins were in vitro-translated in the
presence of
35S met, and their ability to be retained onto a GST-AIP4 fusion protein or control GST adsorbed to glutathione-agarose beads was
analyzed by SDS-PAGE analysis. The input lanes (7, 8, 15, 16, 23, 24, 25) show the different in vitro-translated products prior to incubation with the
beads. Two concentrations of in vitro translated DTX (0.5 or 3 ml, indicated by + and + respectively) were tested. White lines indicate that intervening
lanes have been spliced out.
doi:10.1371/journal.pone.0002735.g007
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the Itch family such as Nedd4 are still present in these cells and
may partially replace it. Nevertheless the reintroduction of AIP4 in
ID-FL cells is required to fully restore the kinetics of Notch
degradation. We also propose that AIP4/Itch mainly catalyses the
formation of polyubiquitin chains through the lysine 29 of
ubiquitin, as is the case for two of its substrates, DTX and itself
[12]. Hence Notch seems to behave like DTX towards AIP4, both
regarding the type of isopeptide linkage used and the localisation
and time of the ubiquitination events in the endocytic pathway.
It should be mentioned that other ubiquitination events
affecting Notch and catalyzed by other E3 ubiquitin ligases could
happen before or after Itch requirement. The RING E3 ubiquitin
ligase c-cbl, which was described to be necessary for Notch
lysosomal degradation [31] could fulfill this function. On the other
hand, other receptors have been recently described to be
endocytosed without any ubiquitination event, this step taking
place later. This was recently demonstrated for EGFR, where
mutating all lysine residues in the kinase domain did not affect the
internalization rate of the receptors [32]. More complicated
situations may be envisaged, as recently shown for the interferon
receptor IFNAR1, where ubiquitinations through K48 and K63
linkages on specific sites are required for the receptor to be
internalized after ligand stimulation, the efficiency of this process
being affected by the ubiquitination-dependent exposure of a
linear endocytic motif present in the cytoplasmic tail of the
receptor [33]. Therefore mechanisms underlying Notch receptor
endocytosis are not completely understood yet, although its
ubiquitination through K29 chains represents a signature of a
very specific Itch-dependent spatiotemporal step.
Parallels and Differences between drosophila Su(dx) and
mammalian Itch/AIP4
The Drosophila Su(dx) gene was described as a negative
regulator of Notch signaling [2–4]. It has been shown that Su(dx)
and Nedd4 regulate the postendocytic sorting of Notch en route to
the late endosome [18,19]. Our data confirm and extend these
observations by identifying the way Notch is degraded and the step
regulated by Itch. Nedd4 suppression in drosophila leads to
Notch-dependent and ligand-independent activation of Notch
target genes [18], possibly by stabilizing the Notch-Dx complex
and facilitating c-secretase proteolytic cleavage of Notch. We did
not observe any constitutive activation of Notch in Itch -/- cells,
although Notch was fully activable by EDTA treatment even in
the absence of Itch. This discrepancy might be related to the
different protein complexes formed in drosophila and in
mammals. Indeed it has been well documented that Su(dx) WW
domains directly interact with a PPSY motif in the drosophila
Notch intracellular domain [18,19,25]. Our data using GST pull-
down experiments show that unmodified forms of Notch or AIP4
cannot stably interact together. Moreover the crucial tyrosine
present in the interaction motif of Drosophila Notch is absent in
mammalian Notch, and the presence of the C-terminal part of
mammalian Notch does not affect its ability to be ubiquitinated by
Itch. Taken together, these results suggest that mammalian Notch
does not use such a motif to interact with Itch. Therefore the
protein complexes containing Notch and Su(dx) in drosophila
might be different from those containing Notch and Itch/AIP4
and found during endocytosis in mammals.
Qiu et al [20] concluded that murine Itch binds to the N-
terminal portion of Notch intracellular domain, although they did
not prove that the interaction was direct. We were able to co-
immunoprecipitate endogenous Notch and Itch only when
solubilizing membrane complexes with the mild detergent
digitonine. Therefore such membrane Notch-containing complex-
es might also contain other proteins, the presence of which is
necessary to connect Notch and Itch. The same type of events
have been described in mammals for other HECT-E3 ubiquitin
ligases. In particular after TGFb stimulation, Smurf1 and Smurf2
participate in the ubiquitination and degradation of TGFb
receptor and SnoN, through their association with Smad7 and
Smad2 respectively [34–36].
Based on genetical and biochemical data, we tested in vitro two
possible bridging factors between Itch and Notch, DTX and
numb. DTX in mammals has been shown to interact with Itch
[12] and Notch [37], and is associated with endocytic vesicles [12].
Numb was proposed to promote Notch receptor ubiquitination
and degradation of its intracellular domain after activation [38].
On the other hand, numb targets Gli1 for Itch-dependent
ubiquitination [39]. Although both proteins could constitute good
candidates, their presence did not improve Notch binding to GST-
AIP4. Finally we tested beta-arrestin 1 and 2, since b-arrestin 1
was very recently demonstrated to be necessary to promote the
interaction between AIP4 and activated CXCR4 [40]. Further-
more b-arrestin 2 drosophila ortholog, Krz, was described as a
negative regulator of Notch signaling acting in a deltex-dependent
manner [29]. However these factors did not facilitate Notch
binding to AIP4 in vitro. Therefore we conclude that either other
Figure 8. AIP4/Itch associates with Notch in non-activated cells.
Digitonin solubilized extracts from MD-FL cells were immunoprecipi-
tated with antibodies for Notch EC (anti-HA antibody, lane 1), Notch IC
(lane 2), a rabbit preimmune serum (PI, lane 3) or rabbit anti Itch (lane
4). The immunoprecipitates were analyzed by SDS-PAGE followed by
immunoblotting with monoclonal anti-Itch and anti-Notch as indicated.
Lane 5 contains an aliquot of the starting material. Bottom panel shows
a longer exposure of the anti-Notch blot allowing detection of p120 in
lane 4.
doi:10.1371/journal.pone.0002735.g008
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Notch-Itch interaction.
What happens when Notch is activated?
Our results show that activation of Notch FL is not affected by
the presence of Itch. However both types of fates, Itch-dependent
Notch degradation on one hand, ligand-dependent Notch
activation on the other hand, rely on endocytosis of the receptor
[41]. One can imagine two possibilities: in the first model, Itch is
associated with Notch complexes at the membrane, then ligand
activation and ADAM cleavage produce a new form which can no
longer interact with Itch, thus allowing Notch sorting to different
vesicles where the interaction with c-secretase elements and
subsequent cleavage can occur. Alternatively Itch association
occurs after sorting of activated Notch to the vesicles where it is
cleaved by the c-secretase complex, and thus can happen only by
default on the receptor molecules which have not been activated.
This hypothesis is however difficult to reconcile with the fact that
Itch colocalizes with Hrs-positive vesicles [7,12,40] and that c-
secretase cleavage seems to occur downstream of these vesicles
[41–43]. Irrespective of the model, further experiments are
required to characterize the discriminating events and the partners
involved in the sorting.
Materials and Methods
Reagents, constructs and cellular biochemical studies
Antibodies were used at the indicated dilutions for western blot
and supplied by Santa Cruz (anti-EGFR, dilution 4000), BD
Transduction Laboratories (monoclonal anti-Itch and anti-
GM130, diluted respectively 3000 and 800 fold), Abgent
(polyclonal anti-Itch), Sigma (anti-Flag M2), Molecular Probes,
Inc. (Alexa FluorH conjugates), Invitrogen (rabbit anti-GFP,
dilution 5000), Cell Signaling (anti Notch V1744, dilution 2000)
or provided by J.T. August (anti-LAMP1, obtained from the
Developmental Studies Hybridoma Bank developed under the
auspices of the NICHD and maintained by the University of Iowa,
Department of Biological Sciences, Iowa City, IA 52242). Anti-
Notch IC antibody was described in [22]. Expression vectors were
gifts of A. Atfi (INSERM U482, Paris, France, AIP4 and AIP4DN
(C830A)), J. Aster (Harvard Medical School, Boston, USA, Notch
FL(HA) retroviral vector), S. Conner (The Scripps Research
Institute, La Jolla, USA, numb), R. Kopan (Washington
University, St Louis, USA, Notch IC), M. Treier (EMBL,
Heidelberg, Germany, 66HIS-Ub), M. Zerial (Max-Planck-
Institute of Molecular Cell Biology and Genetics, Dresden,
Germany, rab5DN-GFP). GST-AIP4 was obtained from A.
Angers (Universite ´ de Montre ´al, Canada). DAPT was from
Calbiochem. Lactacystin and Leupeptin were from Sigma and
used respectively at 10 and 100 mM.
MD-FL and ID-FL cell lines were established by retroviral
transduction: High titers of recombinant Notch FL(HA) viruses
were obtained 48 h after transfection of the Plat-E ecotropic
packaging cell line with retroviral expression plasmids (gifts of J.
Aster, Harvard medical school, Boston, USA). After retroviral
transduction of the MD and ID cell lines (Mouse embryonic
fibroblasts derived from WT or Itch-/- animals [12]), clonal
populations were obtained by limiting dilution.
Transfections: Ca-phosphate for HEK293T, Fugene 6 (Roche)
for Plat-E, Fugene HD (Roche) for MEF cell lines, according to
manufacturer’s instructions.
Cell cultures, immunofluorescence, immunoprecipitations and
immunoblots experiments were performed as previously described
[12]. For immunofluorescence, images were acquired with 0,3 mm
sections using an Axioplan 2 imaging with Apotome system (Carl
Zeiss MicroImaging Inc., Le Pecq, France). The magnification for
all photographs was 636.
Ubiquitin-conjugates purification
Ni sepharose purification: 293T cells were harvested 24 h after
transfection and lysed in 8 M urea, 0.1 M NaH2PO4, 10 mM
Tris-Hcl (pH 8), 1% Triton X-100 and 20 mM Imidazole at room
temperature. His-Ub conjugated proteins were purified on
chelating Sepharose beads (Pharmacia), prealably charged with
Nickel. Ni-bound proteins were washed extensively with the same
buffer, then with a pH 6.3 buffer and eluted in Laemmli before
western blot analysis.
Denaturing immunoprecipitation: 293T cells were collected
24 h after transfection, washed in PBS buffer and lysed in 50 mM
Tris-Hcl (pH 8.0), 1% Triton X-100, 150 mM NaCl supplement-
ed with 16protease inhibitor cocktail (Roche) and 5 mM N-
ethylmaleimide (Sigma). After removing of the insoluble material
by centrifugation, extracts were boiled in 1% SDS for 5 minutes.
After neutralization of SDS by 10-fold dilution in Triton buffer,
immunoprecipitation was performed.
HA antibody or EGF uptake assays
After washing the cells in serum-free medium, they were
incubated at 4uC for 30 min with anti-HA-Al488 (or a mixture
with EGF-Al555), then washed again and incubated in serum-free
medium for various periods of time at 37uC. The cells were then
quickly rinsed in cold PBS, fixed and processed for immunostain-
ing. If stained additionally with anti-LAMP-1, this was applied
after the permeabilization step.
Suborganellar fractionation
The preparation of early and late endosomal enriched fractions
from MD-FL or ID-FL cells was performed after 16 h of leupeptin
treatment according to [44]. Briefly, cells were washed and
harvested in ice-cold PBS, pelleted and resuspended in 250 mM
Sucrose, 20 mM Tris pH 7.9, 3 mM Imidazole. Cells were broken
with a dounce (pestle B), the post nuclear supernatant (P) was
collected after centrifugation at 3000 rpm for 10 min. It was then
brought to 40.6% sucrose, loaded at the bottom of an
ultracentrifuge tube, and sequentially overlaid with 35%, 25%
and 8.6% sucrose containing buffers. The gradient was centrifuged
at 35000 rpm for one hour at 4uC in a SW55Ti rotor. Early and
late endosomal fractions were collected at the 35/25 and 25/8.6%
sucrose interfaces respectively.
Activation by EDTA treatment
Notch heterodimer dissociation was obtained as described [21].
After washing with HBSS (Gibco-BRL), the cells were incubated
in pre-warmed 10 mM EDTA-containing HBSS for 15 min at
37uC. The medium was replaced by PBS and cells were directly
collected and lysed. When necessary, DAPT (5 mM) was added
1 h before activation and maintained during the treatments.
GST pull-down analysis
In vitro-translated proteins were synthesized in a reticulocyte
lysate-coupled transcription/translation system (Promega), in the
presence of
35S methionine. Approximately equal amounts of
glutathione-S transferase (GST) alone or in fusion with AIP4 [17],
as estimated from a Coomassie-stained gel, were bound to
glutathione-Agarose (Sigma). The in vitro translations were
incubated for 2 hours at 4uC with these beads in 1% Triton-
containing buffer. The beads were then extensively washed in the
Regulation of Notch by Itch
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Laemmli buffer, subjected to SDS-PAGE analysis followed by
fluorography.
Supporting Information
Figure S1 MD-FL and ID-FL cells exhibit similar amounts of
Notch at the membrane: Surface proteins of both cell lines were
labelled with NHS-biotin for 1 hour at 4uC (lanes +). Whole cell
extracts (lanes 1–4) and fractions retained on streptavidin-agarose
(lanes 5–8) were analyzed by immunoblotting with anti-Notch.
Note that only p120 is detected in lanes 6 and 8, confirming the
non-contamination with intracellular Notch. As a positive control,
EGFR was detected at the membrane, and GM130 was used as a
negative control. Immunoreactivity of the upper blot was
quantified using Quantity One software (Biorad Lab.). For each
cell line, the relative amount of membrane Notch was calculated as
the ratio between «streptavidin-purified» and «extract» signals. It
was estimated to 3.5% in MD-FL cells and 3.3% in ID-FL cells.
Found at: doi:10.1371/journal.pone.0002735.s001 (1.10 MB TIF)
Figure S2 Activation of EGFR in MD-FL and ID-FL cells. Anti-
HA antibody (green) and EGF (red) uptake assays were performed
concomitantly in MD-FL (A) or ID-FL (B) cells. Insets represent
enlargements (eightfold) of the boxed regions.
Found at: doi:10.1371/journal.pone.0002735.s002 (5.62 MB TIF)
Figure S3 Ubiquitination of EGFR: HEK293T were transfected
with various Ub vectors (as in figure 6B). Ub K0 indicates a
mutant where all lysine residues have been replaced by arginine.
24 hours after transfection, cells were treated with EGF for
5 minutes, extracts were prepared and immunoprecipitated with a
mouse anti-EGFR (Santa Cruz sc-120). Ubiquitinated products
were revealed by western blotting with anti-VSV antibody and
controlled by western blotting with rabbit anti-EGFR (sc-03). A
similar smear was observed with all ubiquitin constructs, even K0,
in accordance with published data showing that multiubiquitina-
tion was mostly produced after EGFR activation.
Found at: doi:10.1371/journal.pone.0002735.s003 (0.94 MB TIF)
Figure S4 K29-linked polybiquitination of Notch is increased by
cotransfected AIP4 and inhibited by AIP4DN. HEK 293T were
transfected with expression vectors encoding Notch FL(HA), AIP4,
AIP4DN and Ub K29 as indicated. The experiment was
performed as in figure 6B. Immunoprecipitates and extracts were
respectively analyzed by western blotting with anti-VSV and anti-
Notch.
Found at: doi:10.1371/journal.pone.0002735.s004 (0.44 MB TIF)
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